Cargando…
The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults
Serum creatinine level begins to increase after a decrease in glomerular filtration rate (GFR) by 50% and more, so the question emerged about a more accurate method of determining GFR. The study aimed to determine the role of renal damage markers in the diagnosis of early-stage renal disease in pati...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321499/ https://www.ncbi.nlm.nih.gov/pubmed/35928354 http://dx.doi.org/10.25122/jml-2022-0062 |
_version_ | 1784756060164194304 |
---|---|
author | Tsaryk, Iryna Pashkovska, Nataliia |
author_facet | Tsaryk, Iryna Pashkovska, Nataliia |
author_sort | Tsaryk, Iryna |
collection | PubMed |
description | Serum creatinine level begins to increase after a decrease in glomerular filtration rate (GFR) by 50% and more, so the question emerged about a more accurate method of determining GFR. The study aimed to determine the role of renal damage markers in the diagnosis of early-stage renal disease in patients with latent autoimmune diabetes in adults (LADA). We included 84 patients with diabetes mellitus (DM) and chronic kidney disease (CKD) caused by diabetic kidney disease (DKD), as well as 25 representatives of the control group. Patients were divided into three groups – 43 people with LADA, 21 with type 1 diabetes mellitus (T1DM), and 20 patients with type 2 diabetes mellitus (T2DM). GFR was assessed using six formulas after establishing the category of GFR and albuminuria. The GFR rate estimated by the CKD-EPI formula in patients with LADA and DKD did not significantly differ from that of CKD-EPI cysC, slightly different from MDRD GFR (10.6% higher, respectively) but 21.9% lower compared to CG formula. In patients with LADA and T1DM, GFR was higher in cases with existing albuminuria, regardless of the formulas used. Thus, the non albuminuria phenotype is accompanied by a greater degree of renal impairment, which indicates the need to determine serum cystatin C in the early stages of LADA. Cystatin C levels are the most accurate, early, and independent predictor of the development and progression of CKD in patients with DM, including LADA. |
format | Online Article Text |
id | pubmed-9321499 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Carol Davila University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-93214992022-08-03 The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults Tsaryk, Iryna Pashkovska, Nataliia J Med Life Original Article Serum creatinine level begins to increase after a decrease in glomerular filtration rate (GFR) by 50% and more, so the question emerged about a more accurate method of determining GFR. The study aimed to determine the role of renal damage markers in the diagnosis of early-stage renal disease in patients with latent autoimmune diabetes in adults (LADA). We included 84 patients with diabetes mellitus (DM) and chronic kidney disease (CKD) caused by diabetic kidney disease (DKD), as well as 25 representatives of the control group. Patients were divided into three groups – 43 people with LADA, 21 with type 1 diabetes mellitus (T1DM), and 20 patients with type 2 diabetes mellitus (T2DM). GFR was assessed using six formulas after establishing the category of GFR and albuminuria. The GFR rate estimated by the CKD-EPI formula in patients with LADA and DKD did not significantly differ from that of CKD-EPI cysC, slightly different from MDRD GFR (10.6% higher, respectively) but 21.9% lower compared to CG formula. In patients with LADA and T1DM, GFR was higher in cases with existing albuminuria, regardless of the formulas used. Thus, the non albuminuria phenotype is accompanied by a greater degree of renal impairment, which indicates the need to determine serum cystatin C in the early stages of LADA. Cystatin C levels are the most accurate, early, and independent predictor of the development and progression of CKD in patients with DM, including LADA. Carol Davila University Press 2022-06 /pmc/articles/PMC9321499/ /pubmed/35928354 http://dx.doi.org/10.25122/jml-2022-0062 Text en ©2022 JOURNAL of MEDICINE and LIFE https://creativecommons.org/licenses/by/3.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Original Article Tsaryk, Iryna Pashkovska, Nataliia The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults |
title | The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults |
title_full | The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults |
title_fullStr | The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults |
title_full_unstemmed | The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults |
title_short | The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults |
title_sort | role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321499/ https://www.ncbi.nlm.nih.gov/pubmed/35928354 http://dx.doi.org/10.25122/jml-2022-0062 |
work_keys_str_mv | AT tsarykiryna theroleofrenaldamagemarkersinthediagnosisofearlystagesofkidneyinjuryinpatientswithlatentautoimmunediabetesinadults AT pashkovskanataliia theroleofrenaldamagemarkersinthediagnosisofearlystagesofkidneyinjuryinpatientswithlatentautoimmunediabetesinadults AT tsarykiryna roleofrenaldamagemarkersinthediagnosisofearlystagesofkidneyinjuryinpatientswithlatentautoimmunediabetesinadults AT pashkovskanataliia roleofrenaldamagemarkersinthediagnosisofearlystagesofkidneyinjuryinpatientswithlatentautoimmunediabetesinadults |